Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb;17(2):158-61.
doi: 10.1007/s12603-012-0090-4.

Evaluation of vitamin D medicines and dietary supplements and the physicochemical analysis of selected formulations

S Garg  1 , D Sabri, J Kanji, P S Rakkar, Y Lee, N Naidoo, D Svirskis
Affiliations

Evaluation of vitamin D medicines and dietary supplements and the physicochemical analysis of selected formulations

S Garg et al. J Nutr Health Aging. 2013 Feb.

Abstract

Context: Vitamin D is purported to offer wide ranging and numerous health benefits leading to increased interest from manufacturers of medicines and dietary supplements. Elderly patients frequently require vitamin D supplementation due to reduced sun exposure and dietary intake. There are ever increasing numbers of vitamin D formulations in the global market. However, due to a lack of regulatory restrictions for some of these products the quality of these dosage forms can be of some concern.

Objectives: To study vitamin D formulations available in the global market and evaluate physic-chemical properties of selected formulations from the New Zealand market.

Method: The first component of this study consisted of a search for different vitamin D formulations available in selected countries. The second component of the study involved assaying selected vitamin D formulations available in New Zealand. Vitamin D was extracted from capsule, tablet and emulsion formulations and quantified using a validated High Performance Liquid Chromatography (HPLC) method.

Results: Of the 14 analysed formulations, only 60% were within 100±10 % of the label claim. The two registered, prescription formulations available exhibited vitamin D levels of 90±4% and 97±2% of the labeled amount, while non-registered, non-prescription dietary supplements had vitamin D levels ranging from 8±2% to 201±29% of the labeled amount.

Conclusions: Dietary supplements do not require strict regulation and showed a large variation in the percentage label claim of vitamin D. Prescription formulations which are more strictly regulated gave content values within standard acceptance ranges. Vitamin D has proven health benefits and also the potential to cause harm, therefore there is a need for tougher regulations of dietary supplements to ensure acceptable quality.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Strengths of vitamin D3 formulations available in different countries. Total number of formulations per country; New Zealand = 31, Australia = 33, USA = 48, UK = 29, Japan = 79, Canada = 58, India = 40 and Malaysia = 15. Note, 40 IU = 1 µg
Figure 2
Figure 2
Average percentage of label claim for various formulations; TAB = tablet, SGC = soft gellatin capsule, HGC1 = hard gellatin capsule and EML = emulsion (error bars represents standard deviation, n=3). Dark grey bars represent formulations within 100 ± 10% of the label claim, black bars formulations above 110% and light grey bars formulations under 90%
See this image and copyright information in PMC

References

    1. Gueli N, Verrusio W, Linguanti A, Di Maio F, Martinez A, Marigliano B, et al (2011) Vitamin D: Drug Of The Future. A New Therapeutic Approach. Archives of Gerontology and Geriatrics(2455): 1–6. - PubMed
    1. Lappe J.M. The Role of Vitamin D in Human Heallh: A Paradigm Shift. Journal of Evidence-Based Complementary & Alternative Medicine. 2011;16(l):58–72. 10.1177/1533210110392952 - DOI
    1. Holick M.F. Vitamin D deficiency. New England Journal of Medicine. 2007;357(3):266–281. 10.1056/NEJMra070553 PubMed PMID: 17634462. - DOI - PubMed
    1. Palomer X., Gonzalez-Clemente J.M., Blanco-Vaca F., Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes, Obesity and Metabolism. 2008;10(3):185–197. 10.1111/j.1463-1326.2007.00710.x PubMed PMID: 18269634. - DOI - PubMed
    1. Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. The American Journal of Clinical Nutrition. 2004;79(3):362. PubMed PMID: 14985208. - PubMed

Publication types

MeSH terms